Squarepoint’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Squarepoint’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$389K	Buy	+12,952	New	+$429K	﹤0.01%	3510
2025 Q4	–	Sell	-6,099	Closed	-$211K	–	4491
2025 Q3	$211K	Buy	+6,099	New	+$195K	﹤0.01%	3906
2025 Q2	–	Sell	-8,154	Closed	-$205K	–	4691
2025 Q1	$205K	Buy	+8,154	New	+$206K	﹤0.01%	4001
2023 Q2	–	Sell	-18,251	Closed	-$705K	–	3719
2023 Q1	$705K	Buy	+18,251	New	+$750K	﹤0.01%	2110
2019 Q2	–	Sell	-8,863	Closed	-$1.04M	–	2482
2019 Q1	$1.04M	Buy	+8,863	New	+$894K	0.01%	1087
2018 Q4	–	Sell	-7,814	Closed	-$879K	–	2050
2018 Q3	$879K	Sell	7,814 -4,644	-37%	-$491K	0.01%	1052
2018 Q2	$1.15M	Buy	12,458 +2,258	+22%	+$219K	0.02%	843
2018 Q1	$1.02M	Buy	+10,200	New	+$1.1M	0.02%	807

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Squarepoint's LKFT Position: Q1 2026 in Review

Squarepoint opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 12,952 shares worth $389K. The stake represents ﹤0.01% of the portfolio and ranks #3510 among its holdings. This is a return to the name: Squarepoint previously reported a position in LKFT as recently as Q3 2025.

Squarepoint first reported a position in LKFT in Q1 2018 and has held it in 8 quarters since. The position peaked at $1.15M in Q2 2018. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Squarepoint held 12,952 shares of Lakefront Biotherapeutics American Depositary Shares worth $389K as of Q1 2026.
Lakefront Biotherapeutics American Depositary Shares was a new Squarepoint position in Q1 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3510 holding.
Squarepoint first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and has held it in 8 quarters since.
Squarepoint's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.15M in Q2 2018.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.